Spatial patterns of human papillomavirus-associated cancers within the state of Minnesota, 1998-2007

Spatial and Spatio-temporal Epidemiology

Volumn 9, Issue , 2014, Pages 13-21

  Nelson, Erik J ^a   Hughes, John ^a   Kulasingam, Shalini L ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Cancer; HPV; HPV vaccine; Human papillomavirus; Spatial epidemiology

Indexed keywords

WART VIRUS VACCINE;

ANUS CANCER; ARTICLE; BEHAVIORAL RISK FACTOR SURVEILLANCE SYSTEM; CANCER INCIDENCE; CANCER LOCALIZATION; CANCER MORTALITY; CANCER PREVENTION; CANCER SCREENING; CHLAMYDIA; CLUSTER ANALYSIS; GEOGRAPHIC DISTRIBUTION; GONORRHEA; HUMAN; HUMAN PAPILLOMAVIRUS ASSOCIATED CANCER; INCOME; MOUTH CANCER; NEOPLASM; NONHUMAN; PAPANICOLAOU TEST; PAPILLOMAVIRUS INFECTION; PENIS CANCER; PHARYNX CANCER; PRIORITY JOURNAL; SMOKING; UNITED STATES; UTERINE CERVIX CANCER; VACCINATION; VAGINA CANCER; VIRUS CARCINOGENESIS; VULVA CANCER; WART VIRUS; ADULT; EPIDEMIOLOGY; FEMALE; GENITAL NEOPLASMS, FEMALE; GENITAL NEOPLASMS, MALE; HEALTH SURVEY; INCIDENCE; MALE; OROPHARYNGEAL NEOPLASMS; PAPILLOMAVIRUS INFECTIONS; RISK FACTOR; VIROLOGY;

ADULT; FEMALE; GENITAL NEOPLASMS, FEMALE; GENITAL NEOPLASMS, MALE; HUMANS; INCIDENCE; MALE; MINNESOTA; OROPHARYNGEAL NEOPLASMS; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; POPULATION SURVEILLANCE; RISK FACTORS;

EID: 84896537099     PISSN: 18775845     EISSN: 18775853     Source Type: Journal    
DOI: 10.1016/j.sste.2014.02.003     Document Type: Article

References (53)

1. ACOG Committee Opinion No. 463: Cervical cancer in adolescents: screening, evaluation, and management. Obstet Gynecol 2010, 116(2 Pt. 1):469-472. American College of Obstetricians and Gynecologists (ACOG).
2. Ahmed B., Jacob P., Allen F., Benowitz N. Attitudes and practices of hookah smokers in the San Francisco Bay Area. J Psychoactive Drugs 2011, 43(2):146-152.
3. Albo, M (2011). "Gayest Cities in America." Advocate.com. Retrieved January 12, 2011, from: <>. http://www.advocate.com/travel/2011/01/12/gayest-cities-america-february-2011/.
4. Anderson R.M., Garnett G.P. Mathematical models of the transmission and control of sexually transmitted diseases. Sex Transm Dis 2000, 27(10):636-643.
5. Anttila T., Saikku P., Koskela P., Bloigu A., et al. Serotypes of Chlamydia trachomatis and risk for development of cervical squamous cell carcinoma. JAMA 2001, 285(1):47-51.
6. Besag J., York J., Mollie A. Bayesian image-restoration, with 2 applications in spatial statistics. Ann Inst Stat Math 1991, 43(1):1-20.
7. Bouvard V., Baan R., Straif K., Grosse Y., et al. A review of human carcinogens-Part B: biological agents. Lancet Oncol 2009, 10(4):321-322.
8. U.S. Census Bureau. (2012). 2010 American Community Survey. Retrieved January 15, 2013, from <>. http://quickfacts.census.gov/qfd/states/27000lk.html.
9. Centers for Disease Control and Prevention (CDC) (2004). The health consequences of smoking: a report of the Surgeon General. Office of the Surgeon General, Office on Smoking and Health.
10. Centers for Disease Control and Prevention (CDC). (2008). Behavioral Risk Factor Surveillance System Survey Data. (Retrieved May 25, 2013).
11. Centers for Disease Control and Prevention (CDC). (2010). National Immunization Survey - Teen. Retrieved May 25, 2013, from <>. http://www.cdc.gov/vaccines/stats-surv/nisteen/data/tables_2008.htm#overall.
12. Recommendations on the use of quadrivalent human papillomavirus vaccine in males-Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2011, 60(50):1705-1708. Centers for Disease Control and Prevention (CDC).
13. Centers for Disease Control and Prevention (CDC). (2012). Genital HPV Infection Fact Sheet. Retrieved May 29, 2012, 2012, from <>. http://www.cdc.gov/std/HPV/STDFact-HPV.htm#common/.
14. Centers for Disease Control and Prevention (CDC). (2013). "Statistics and Surveillance: 2011 NIS-Teen Vaccination Coverage Table Data." Retrieved 3/19/13, from <>. http://www.cdc.gov/vaccines/stats-surv/nisteen/data/tables_2011.htm#overall.
15. Cogliano V., Baan R., Straif K., Grosse Y., et al. Carcinogenicity of human papillomaviruses. Lancet Oncol 2005, 6(4):204.
16. Daling J.R., Madeleine M.M., Johnson L.G., Schwartz S.M., et al. Human papillomavirus, smoking, and sexual practices in the etiology of anal cancer. Cancer 2004, 101(2):270-280.
17. Dickerson J.B., Smith M.L., Ory M.G. Increasing uptake of Gardasil among American adolescents: comparisons with the history of Hepatitis B vaccination. Hum Vaccin 2011, 7(2):211-219.
18. Dillner J., Lehtinen M., Bjorge T., Luostarinen T., et al. Prospective seroepidemiologic study of human papillomavirus infection as a risk factor for invasive cervical cancer. J Natl Cancer Inst 1997, 89(17):1293-1299.
19. U.S. Food and Drug Adminstration (FDA). (2009, February 16, 2010). FDA approves new vaccine for prevention of cervical cancer. Retrieved May 29, 2012, from <>. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm187048.htm/.
20. Garland S.M., Hernandez-Avila M., Wheeler C.M., Perez G., et al. Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases. N Engl J Med 2007, 356(19):1928-1943.
21. Garnett G.P., Anderson R.M. Balancing sexual partnerships in an age and activity stratified model of HIV transmission in heterosexual populations. IMA J Math Appl Med Biol 1994, 11(3):161-192.
22. Garnett G.P., Hughes J.P., Anderson R.M., Stoner B.P., et al. Sexual mixing patterns of patients attending sexually transmitted diseases clinics. Sex Transm Dis 1996, 23(3):248-257.
23. Ghani A.C., Swinton J., Garnett G.P. The role of sexual partnership networks in the epidemiology of gonorrhea. Sex Transm Dis 1997, 24(1):45-56.
24. Gillison M.L., Chaturvedi A.K., Lowy D.R. HPV prophylactic vaccines and the potential prevention of noncervical cancers in both men and women. Cancer 2008, 113(10 Suppl):3036-3046.
25. Hibbitts S. Should boys receive the human papillomavirus vaccine? Yes. BMJ 2009, 339:b4928.
26. Hughes, J and Cui, X (2013). ngspatial: Classes for Spatial Data, Minneapolis, MN (R package version 1.0-1).
27. Hughes J., Haran M. Dimension reduction and alleviation of confounding for spatial generalized linear mixed models. J Royal Stat Soc B Stat Methodol 2013, 75:139-159.
28. Hull S.C., Caplan A.L. The case for vaccinating boys against human papillomavirus. Public Health Genomics 2009, 12(5-6):362-367.
29. Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. N Engl J Med 2007, 356(19):1915-1927. FUTURE II Study Group.
30. Jones G.L., Haran M., Caffo B.S., Neath R. Fixed-width output analysis for Markov chain Monte Carlo. J Am Stat Assoc 2006, 101(476):1537-1547.
31. Korostil I.A., Peters G.W., Cornebise J., Regan D.G. Adaptive Markov chain Monte Carlo forward projection for statistical analysis in epidemic modelling of human papillomavirus. Stat Med 2012, 32(11):1917-1953.
32. Koskela P., Anttila T., Bjorge T., Brunsvig A., et al. Chlamydia trachomatis infection as a risk factor for invasive cervical cancer. Int J Cancer 2000, 85(1):35-39.
33. Kulldorff M. A spatial scan statistic. Commun Stat 1997, 26:1481-1496.
34. Madeleine M.M., Anttila T., Schwartz S.M., Saikku P., et al. Risk of cervical cancer associated with Chlamydia trachomatis antibodies by histology, HPV type and HPV cofactors. Int J Cancer 2007, 120(3):650-655.
35. Minnesota Department of Health (MDH). (2009). 2008 STD Surveillance Statistics. Retrieved January 10, 2013, from <>. http://www.health.state.mn.us/divs/idepc/dtopics/stds/stats/stdsurvrpts2008.html.
36. Moyer V.A. Screening for cervical cancer: U.S. preventive services task force recommendation statement. Ann Intern Med 2012, 14:2012.
37. Munoz, N, X Castellsague, AB de Gonzalez and L Gissmann (2006). Chapter 1: HPV in the etiology of human cancer. Vaccine 24 Suppl 3: S3/1-10.
38. Niccolai L.M., Julian P.J., Bilinski A., Mehta N.R., et al. Geographic poverty and racial/ethnic disparities in cervical cancer precursor rates in Connecticut, 2008-2009. Am J Public Health 2013, 103(1):156-163.
39. Parkin D.M. The global health burden of infection-associated cancers in the year 2002. Int J Cancer 2006, 118(12):3030-3044.
40. Poynten I.M., Stein A.N., Conway E.L., Prestage G., et al. Geographical clustering of anal cancer incidence in Australia. Sex Health 2012, 9(6):509-512.
41. R: A language and environment for statistical computing 2013, R Development Core Team, R Foundation for Statistical Computing, Vienna, Austria.
42. Rahman M., Laz T.H., Berenson A.B. Geographic variation in human papillomavirus vaccination uptake among young adult women in the United States during 2008-2010. Vaccine 2013, 31(47):5495-5499.
43. Reich B.J., Hodges J.S., Zadnik V. Effects of residual smoothing on the posterior of the fixed effects in disease-mapping models. Biometrics 2006, 62(4):10p.
44. Saslow D., Solomon D., Lawson H.W., Killackey M., et al. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. CA Cancer J Clin 2012, 62(3):147-172.
45. Scarinci I.C., Garcia F.A., Kobetz E., Partridge E.E., et al. Cervical cancer prevention: new tools and old barriers. Cancer 2010, 116(11):2531-2542.
46. Schiffman M., Castle P.E., Jeronimo J., Rodriguez A.C., et al. Human papillomavirus and cervical cancer. Lancet 2007, 370(9590):890-907.
47. Smith J.S., Bosetti C., Munoz N., Herrero R., et al. Chlamydia trachomatis and invasive cervical cancer: a pooled analysis of the IARC multicentric case-control study. Int J Cancer 2004, 111(3):431-439.
48. Smith J.S., Munoz N., Herrero R., Eluf-Neto J., et al. Evidence for Chlamydia trachomatis as a human papillomavirus cofactor in the etiology of invasive cervical cancer in Brazil and the Philippines. J Infect Dis 2002, 185(3):324-331.
49. Su Y.S., Gelman A., Hill J., Yajima M. Multiple imputation with diagnostics (mi) in R: opening windows into the black box. J Stat Software 2011, 45(2):1-31.
50. U.S. Preventive Services Task Force (USPSTF). (2012). Screening for Oral Cancer. U.S. Preventive Services Task Force Recommendation Statement. Retrieved May 29, 2012, from <>. http://www.uspreventiveservicestaskforce.org/3rduspstf/oralcan/oralcanrs.htm.
51. Wallin K.L., Wiklund F., Luostarinen T., Angstrom T., et al. A population-based prospective study of Chlamydia trachomatis infection and cervical carcinoma. Int J Cancer 2002, 101(4):371-374.
52. Watson M., Saraiya M., Ahmed F., Cardinez C.J., et al. Using population-based cancer registry data to assess the burden of human papillomavirus-associated cancers in the United States: overview of methods. Cancer 2008, 113(10 Suppl):2841-2854.
53. Weinstock H., Berman S., Cates W. Sexually Transmitted disease among American youth: incidence and prevalence estimates, 2000. Perspect Sex Reprod Health 2004, 36(1):6-10.